Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 1.000 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.529 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.524 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.517 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.507 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.503 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.497 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.486 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.483 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.482 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.480 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.477 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.472 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.471 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.470 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.469 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.469 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.468 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.466 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.466 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.464 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.464 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.464 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.459 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.458 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.453 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.452 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.450 | |
| 3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.450 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.447 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
| 5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.445 | |
| 2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.444 | |
| 3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.441 | |
| 4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.441 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.441 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.440 | |
| 3erk | SB4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 |